Partner With Us NRI

Company details

6M Return -32.81%
1Y Return 143.90%
Mkt Cap.(Cr) 8.11
Volume 172
Div Yield 0.00%
OI Chg %
Volume 172

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 0.07 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -38,577.79
LAST 3M 77,375.96 -53,201.90
LAST 6M 142,231.38 -196,897.34
LAST 12M 206,053.08 -176,593.86
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found


  • About Company
  • Company Info
  • Listing Info
  • Incorporated on 4 Jun.`92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. The company is managed by managing director D C Jain. WDPL had come out with a Rs 4-cr public issue in Aug.`94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.`96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market. The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, Saccharin and Aspartame. The Company has added a new liquid oral plant in Bhiwadi, Rajasthan. It has obtained ISO 9002 certification with double accredition from ABS Quality Evaluation Inc Texas and by Registrar of Accredition Board of USA. Welcure has also entered into an agreement with Bihar Drugs and Chemicals Ltd, a government of Bihar undertaking, for manufacturing their products in its factory on loan basis. During the year 2000-01 the company had launched some products like CEZEN,DIMCIN PLUS,OXIN,SPASWIN etc.The company has entered into technical collaboration agreement with Advanced Medical Care Inc New Jersey USA for setting up of joint venture facilities in the existing plant of the company. During the year 2001-02, the company had launched products like B-ZEX, DMART PLUS, DRALPIN, DUKESPAS, DUBAMOL, HISTACURE, KUFFWEL, KINGSPAS, LANAX, PETRIMAX, PEEROSCAM, RENACT, SARVO, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF, X-DRYL. The company has changed its marketing policy from "Sales through Wholesale Distributors" to " Sales at Doorstep" by reaching every corner of the country and by putting dual force on Sales-through sales personnel on one hand and through stockists and distributors on the other hand.

Read More

No Data Found

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524661
NSE Code :
Book Closure Date (Month) : Jul
BSE Group : XT
ISIN : INE331C01017

ICICIdirect Welcure Drugs & Pharmaceuticals Ltd FAQ

You can buy Welcure Drugs & Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Welcure Drugs & Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 23, 2022 10:34 AM the closing price of Welcure Drugs & Pharmaceuticals Ltd was ₹ 6.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 23, 2022 10:34 AM, the market cap of Welcure Drugs & Pharmaceuticals Ltd stood at ₹ 8.11.
The latest PE ratio of Welcure Drugs & Pharmaceuticals Ltd as of May 23, 2022 10:34 AM is 300
The latest PB ratio of Welcure Drugs & Pharmaceuticals Ltd as of May 23, 2022 10:34 AM is 0.18
The 52-week high of Welcure Drugs & Pharmaceuticals Ltd is ₹ 12.08 while the 52-week low is ₹ 2.46 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote